81 – 90 of 113
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Second cancers after testicular cancer diagnosed after 1980 in Sweden
(
- Contribution to journal › Article
- 2009
-
Mark
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(
- Contribution to journal › Scientific review
-
Mark
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
(
- Contribution to journal › Article
-
Mark
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study
(
- Contribution to journal › Article
- 2008
-
Mark
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
(
- Contribution to journal › Article
- 2007
-
Mark
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
(
- Contribution to journal › Article
-
Mark
Icelandic patients in oncology outpatient care: Distress, coping and satisfaction with care
2007) In Bulletin from the Department of Health Sciences, Lund University(
- Thesis › Doctoral thesis (compilation)
-
Mark
Improved outcome after relapse in children with acute myeloid leukaemia
(
- Contribution to journal › Article
-
Mark
Successful treatment of a child with t(15;19)-positive tumor.
(
- Contribution to journal › Article